AXL and hepatocellular carcinoma: Overexpression of AXL has also been found in a variety of other cancers, including clear cell renal cell carcinoma (ccRCC) [12], hepatocellular carcinoma (HCC) [13], and cholangiocarcinoma (CCA) [14], which is associated with poor prognosis of these cancer patients [12–14].